You are required to be logged in to access the full website
User Name: Password:
Click here if you have forgotten your username or password
  • Home
  • Latest News
  • Search
  • About M2 Pharma
  • Subscribe
Business & Finance
Generics
Therapy Areas
Policy & Regulation
Research & Development
People
Therapy Areas: Diabetes
Walgreens helps raise over USD1.4m for JDRF
27 January 2012 - US drugstore chain Walgreens (NYSE:WAG) and the Juvenile Diabetes Research Foundation (JDRF) said on Thursday that Walgreens' community-based programmes raised over USD1.4m (EUR1.1m) for JDRF causes in 2011.

In August last year, customers at over 7,500 Walgreens drugs...

 

 

 

You must be logged in to view the whole article.
Click here if you require signing up

 

 

 

Login
Username:

Password:


Related Headlines

Sydbank analyst sees strong competition for Novo Nordisk's Victoza in USA

KineMed to partner with Pfizer to advance new approaches in metabolic disease

FDA okays Amylin's Type 2 diabetes treatment BYDUREON

Walgreens helps raise over USD1.4m for JDRF

Novo Nordisk to open Type 1 diabetes R&D centre in Seattle

Bridge Bioresearch gets US patent for CD14 molecule

FDA requests more data from Bristol-Myers Squibb, AstraZeneca over dapagliflozin NDA

Vitae Pharmaceuticals secures USD15m in debt financing

Novartis gains approval for Lucentis, launches Galvus in China

Omni Bio to start new Type 1 diabetes, GVHD trials

NICE recommends Eli Lilly's Bydureon prolonged release exenatide for Type 2 diabetes

Islet Sciences signs product manufacturing deal with NeoStem's PCT

FDA approves Roche's Accu-Chek Nano SmartView blood glucose monitor

Oramed applies for US patent for combined oral therapy of diabetes

Designed by Create Marketing
Home | Business & Finance | Generics | Therapy Areas | Policy & Regulation | Research & Development | People | Search | About M2 Pharma | Subscribe
Copyright © 2013